An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, Email Us to receive support.
Sensus Healthcare, Inc. (Nasdaq: SRTS) will host a conference call on May 9, 2024, to discuss the financial results for the first quarter of 2024, provide a business update, and discuss recent and upcoming milestones. Participants can pre-register for the call and access it through various methods.
Sensus Healthcare, Inc. (Nasdaq: SRTS) organizzerà una conferenza telefonica il 9 maggio 2024 per discutere i risultati finanziari del primo trimestre del 2024, fornire un aggiornamento aziendale e discutere gli ultimi e i prossimi traguardi. I partecipanti possono pre-registrarsi per la chiamata e accedervi tramite vari metodi.
Sensus Healthcare, Inc. (Nasdaq: SRTS) organizará una llamada de conferencia el 9 de mayo de 2024 para discutir los resultados financieros del primer trimestre de 2024, proporcionar una actualización sobre el negocio y discutir hitos recientes y próximos. Los participantes pueden pre-registrarse para la llamada y acceder a ella a través de varios métodos.
Sensus Healthcare, Inc. (나스닥: SRTS)는 2024년 1분기 재무 결과를 논의하고 비즈니스 업데이트를 제공하며 최근 및 다가올 주요 이정표에 대해 논의하기 위해 2024년 5월 9일에 컨퍼런스 콜을 개최할 예정입니다. 참가자들은 사전 등록을 하고 다양한 방법으로 접속할 수 있습니다.
Sensus Healthcare, Inc. (Nasdaq : SRTS) organisera une conférence téléphonique le 9 mai 2024 pour discuter des résultats financiers du premier trimestre de 2024, fournir une mise à jour des activités et discuter des jalons récents et à venir. Les participants peuvent se pré-inscrire à l'appel et y accéder par divers moyens.
Sensus Healthcare, Inc. (Nasdaq: SRTS) wird am 9. Mai 2024 eine Telefonkonferenz abhalten, um die Finanzergebnisse des ersten Quartals 2024 zu erörtern, ein Geschäftsupdate zu geben und über kürzliche sowie bevorstehende Meilensteine zu diskutieren. Teilnehmer können sich vorab für den Anruf registrieren und auf verschiedene Weisen darauf zugreifen.
Positive
None.
Negative
None.
BOCA RATON, Fla. , April 18, 2024 (GLOBE NEWSWIRE) -- Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive treatments for both oncological and non-oncological conditions, announces that management will hold a conference call on Thursday, May 9, 2024 at 4:30 p.m. Eastern time to discuss the financial results for the first quarter of 2024. In addition, management will provide a business update and a discussion on recent and upcoming milestones.
Participants are encouraged to pre-register for the conference call using this link. Upon registration participants will receive a unique dial in number that will permit them to bypass the live operator. Participants may pre-register at any time, including up to and after the call start time. Those without internet access or unable to pre-register may access the conference call by dialing, 1-844-481-2811 (U.S. and Canada Toll Free) or 1-412-317-0676 (International). Please direct the operator to be connected to the Sensus Healthcare conference call.
The call will be webcast live and can be accessed at this link, which also may be found in the Investor Relations section of the Company’s website at www.sensushealthcare.com.
Following the conclusion of the conference call, a telephone replay will be available until June 9th, and can be accessed by dialing 877-344-7529 (U.S. Toll Free), 855-669-9658 (Canada Toll Free), or 412-317-0088 (International). At the system prompt, dial the replay code – 9785929 – followed by the # sign. Playback will automatically begin. An archived webcast of the call will also be available in the Investor Relations section of the Company’s website for a period of time.
About Sensus Healthcare, Inc.
Sensus Healthcare, Inc. is a global pioneer in the development and delivery of non-invasive treatments for skin cancer and keloids. Leveraging its cutting-edge superficial radiotherapy (SRT and IG-SRT) technology, the company provides healthcare providers with a highly effective, patient-centric treatment platform. With a dedication to driving innovation in radiation oncology, Sensus Healthcare offers solutions that are safe, precise, and adaptable to a variety of clinical settings.
Contact: LHA Investor Relations Kim Sutton Golodetz 212-838-3777 kgolodetz@lhai.com
# # #
FAQ
When will Sensus Healthcare host a conference call to discuss the first quarter of 2024 financial results?
Sensus Healthcare will host a conference call on Thursday, May 9, 2024, at 4:30 p.m. Eastern time.
What is the focus of the conference call hosted by Sensus Healthcare?
The conference call will focus on discussing the financial results for the first quarter of 2024, providing a business update, and discussing recent and upcoming milestones.
How can participants pre-register for the conference call hosted by Sensus Healthcare?
Participants can pre-register for the conference call using the provided link to receive a unique dial-in number that will allow them to bypass the live operator.
How can participants access the conference call if they are unable to pre-register?
Participants without internet access or unable to pre-register can access the conference call by dialing 1-844-481-2811 (U.S. and Canada Toll Free) or 1-412-317-0676 (International) and direct the operator to connect them to the Sensus Healthcare conference call.
Is there a replay option available for the conference call hosted by Sensus Healthcare?
Yes, a telephone replay will be available until June 9th by dialing 877-344-7529 (U.S. Toll Free), 855-669-9658 (Canada Toll Free), or 412-317-0088 (International) and entering the replay code – 9785929 – followed by the # sign.
sensus healthcare, inc. is a medical device company that is committed to enabling non-invasive and cost-effective treatment of non-melanoma skin cancer and keloids. sensus uses a proprietary low energy x-ray radiation technology known as superficial radiation therapy (srt), which is a result of over a decade of dedicated research and development activities. sensus has successfully incorporated the srt therapy into its portfolio of treatment devices: srt-100™ and srt-100 vision™. srt technology effectively and safely treats oncological and non-oncological skin conditions. for more information, visit http://www.sensushealthcare.com.
